Literature DB >> 33029652

Potentially inappropriate medication in older psychiatric patients.

Gudrun Hefner1, Martina Hahn2, Sermin Toto3, Christoph Hiemke4, Sibylle C Roll2, Jan Wolff5,6, Ansgar Klimke7,8.   

Abstract

PURPOSE: Many psychotropic drugs are listed as potentially inappropriate medication (PIM) in the older population. Potentially inappropriate means that prescription of those drugs in older adults may cause significant harm. The objective of this study was to analyze the prevalence and sort of PIM prescribing in a naturalistic, real-world psychiatric setting.
METHODS: The retrospective analysis gathered data from a large pharmacovigilance study, conducted at 10 psychiatric hospitals. Data from inpatients aged ≥ 65 years were included for the analysis. The number and sort of PIM, as defined by the German PRISCUS list, were controlled by analyzing the patients' medication profile.
RESULTS: In total, 4760 patient cases (59.2% female) with a mean (mean ± standard deviation (SD)) age of 77.33 ± 7.77 years were included into the study. Altogether, 1615 cases (33.9%) received at least 1 PRISCUS-PIM per day (regular and as-needed medication included). The most frequently prescribed PRISCUS-PIM (n = 2144) were zopiclone > 3.75 mg/day (n = 310), lorazepam > 2 mg/day (n = 269), haloperidol > 2 mg/day (n = 252), and diazepam (n = 182). Cases with PRISCUS-PIM were younger (75.7 vs. 78.2 years, p < 0.001) and had a longer (26 vs. 22 days, p < 0.001) hospital length of stay. Replacing benzodiazepines and z-substances, haloperidol > 2 mg, tricyclic antidepressants, first generation antihistaminergic drugs, and clonidine by non-PIM could reduce 69.9% of PRISCUS-PIM-prescribing.
CONCLUSIONS: The prevalence of PRISCUS-PIM is high in the hospitalized psychiatric setting. Rational deprescribing of inappropriate anticholinergics, benzodiazepines, and antipsychotics in the older population is a key component to reduce the risk of adverse drug reactions. More tolerable medications should be prescribed.

Entities:  

Keywords:  Older patients; PRISCUS list; Potentially inappropriate medication; Psychiatry; Psychopharmacology

Year:  2020        PMID: 33029652     DOI: 10.1007/s00228-020-03012-w

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  48 in total

Review 1.  Aging biology and geriatric clinical pharmacology.

Authors:  Allan J McLean; David G Le Couteur
Journal:  Pharmacol Rev       Date:  2004-06       Impact factor: 25.468

2.  [Delirium induced by drug treatment].

Authors:  Christine Back; Markus Wittmann; Ekkehard Haen
Journal:  Ther Umsch       Date:  2011-01

Review 3.  Polypharmacy in the elderly: a literature review.

Authors:  Maryann M Fulton; Elizabeth Riley Allen
Journal:  J Am Acad Nurse Pract       Date:  2005-04

Review 4.  Review on pharmacokinetics and pharmacodynamics and the aging kidney.

Authors:  Christian Aymanns; Frieder Keller; Sebastian Maus; Bertram Hartmann; David Czock
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 8.237

5.  Anticholinergic activity of 107 medications commonly used by older adults.

Authors:  Marci L Chew; Benoit H Mulsant; Bruce G Pollock; Mark E Lehman; Andrew Greenspan; Ramy A Mahmoud; Margaret A Kirshner; Denise A Sorisio; Robert R Bies; Georges Gharabawi
Journal:  J Am Geriatr Soc       Date:  2008-05-26       Impact factor: 5.562

6.  Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population.

Authors:  R M Goldberg; J Mabee; L Chan; S Wong
Journal:  Am J Emerg Med       Date:  1996-09       Impact factor: 2.469

7.  Unnecessary drug use in frail older people at hospital discharge.

Authors:  Emily R Hajjar; Joseph T Hanlon; Richard J Sloane; Catherine I Lindblad; Carl F Pieper; Christine M Ruby; Laurence C Branch; Kenneth E Schmader
Journal:  J Am Geriatr Soc       Date:  2005-09       Impact factor: 5.562

8.  Frailty: an emerging geriatric syndrome.

Authors:  Nasiya Ahmed; Richard Mandel; Mindy J Fain
Journal:  Am J Med       Date:  2007-09       Impact factor: 4.965

9.  The anticholinergic risk scale and anticholinergic adverse effects in older persons.

Authors:  James L Rudolph; Marci J Salow; Michael C Angelini; Regina E McGlinchey
Journal:  Arch Intern Med       Date:  2008-03-10

Review 10.  The challenge of managing drug interactions in elderly people.

Authors:  Louise Mallet; Anne Spinewine; Allen Huang
Journal:  Lancet       Date:  2007-07-14       Impact factor: 79.321

View more
  4 in total

Review 1.  Effectiveness of Interventions to Reduce Potentially Inappropriate Medication in Older Patients: A Systematic Review.

Authors:  Daniela A Rodrigues; Ana I Plácido; Ramona Mateos-Campos; Adolfo Figueiras; Maria Teresa Herdeiro; Fátima Roque
Journal:  Front Pharmacol       Date:  2022-01-24       Impact factor: 5.810

2.  Geographic Variation in Top-10 Prescribed Medicines and Potentially Inappropriate Medication in Portugal: An Ecological Study of 2.2 Million Older Adults.

Authors:  Vânia Rocha; Ana Isabel Plácido; Daniela A Rodrigues; Ana Barbara Tavares; Adolfo Figueiras; Fátima Roque; Maria Teresa Herdeiro
Journal:  Int J Environ Res Public Health       Date:  2022-10-10       Impact factor: 4.614

3.  Potentially inappropriate medications according to PRISCUS list and FORTA (Fit fOR The Aged) classification in geriatric psychiatry: a cross-sectional study.

Authors:  Martin Schulze Westhoff; Adrian Groh; Sebastian Schröder; Phileas Johannes Proskynitopoulos; Kirsten Jahn; Martin Klietz; Benjamin Krichevsky; Dirk O Stichtenoth; Felix Wedegärtner; Stefan Bleich; Helge Frieling; Johannes Heck
Journal:  J Neural Transm (Vienna)       Date:  2022-09-02       Impact factor: 3.850

4.  Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disorders.

Authors:  Jan Wolff; Pamela Reißner; Gudrun Hefner; Claus Normann; Klaus Kaier; Harald Binder; Christoph Hiemke; Sermin Toto; Katharina Domschke; Michael Marschollek; Ansgar Klimke
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.